Page last updated: 2024-11-05

trifluperidol and Hallucinations

trifluperidol has been researched along with Hallucinations in 2 studies

Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)

Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"About 30 patients with, in some cases, recurring paranoid or paranoid-hallucinatory psychoses underwent a long-term treatment--from 2--6 years according to individual cases--with very small doses of powerful neuroleptics (Haloperidol, Triperidol, and occasionally Trisedyl)."3.65[Neuroleptic long term care with extremely low doses in psychotic syndromes of paranoid-hallucination type]. ( König, L; Rossner, M, 1975)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DIPIAZZA, P1
GORI, EC1
LEVI-MINZI, S1
Rossner, M1
König, L1

Other Studies

2 other studies available for trifluperidol and Hallucinations

ArticleYear
[CLINICAL EXPERIMENTATION WITH TRIPERIDOL].
    Rassegna di studi psichiatrici, 1963, Volume: 52

    Topics: Biomedical Research; Electromyography; Extrapyramidal Tracts; Hallucinations; Humans; Mental Disorde

1963
[Neuroleptic long term care with extremely low doses in psychotic syndromes of paranoid-hallucination type].
    Psychiatrie, Neurologie und medizinische Psychologie. Beihefte, 1975, Volume: 20-21

    Topics: Dose-Response Relationship, Drug; Hallucinations; Haloperidol; Humans; Long-Term Care; Paranoid Diso

1975